Advertisement
UK markets close in 3 hours 13 minutes

  • FTSE 100

    8,097.91
    +57.53 (+0.72%)
     

  • FTSE 250

    19,732.02
    +12.65 (+0.06%)
     

  • AIM

    755.45
    +0.76 (+0.10%)
     

  • GBP/EUR

    1.1670
    +0.0025 (+0.21%)
     

  • GBP/USD

    1.2506
    +0.0043 (+0.35%)
     

  • Bitcoin GBP

    51,207.48
    -2,039.09 (-3.83%)
     

  • CMC Crypto 200

    1,357.56
    -25.01 (-1.81%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    83.13
    +0.32 (+0.39%)
     

  • GOLD FUTURES

    2,341.70
    +3.30 (+0.14%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,992.29
    -96.41 (-0.53%)
     

  • CAC 40

    8,021.66
    -70.20 (-0.87%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

These Were the 5 Best Diagnostics Stocks of 2020

Jason Hawthorne, The Motley Fool
·7-min read
These Were the 5 Best Diagnostics Stocks of 2020

It's hard to think of an industry that was more impacted by the 2020 COVID pandemic than diagnostics. The often-overlooked part of the healthcare system sprang into action, testing more than 250 million people last year in the U.S. alone. Co-Diagnostics (NASDAQ: CODX), Aspira Women's Health (NASDAQ: AWH), Fulgent Genetics (NASDAQ: FLGT), GenMark Diagnostics (NASDAQ: GNMK), and Natera (NASDAQ: NTRA) were the five best-performing diagnostics companies last year among those with a market cap above $200 million.

Continue reading